Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
MGRX Mangoceuticals
- 2.480
- +0.040+1.64%
Close Dec 20 16:00 ET
- 2.400
- -0.080-3.23%
Post 20:01 ET
6.17MMarket Cap-0.57P/E (TTM)
2.610High2.260Low215.67KVolume2.520Open2.440Pre Close527.92KTurnover12.40%Turnover RatioLossP/E (Static)2.49MShares16.80052wk High0.46P/B4.31MFloat Cap2.10052wk Low--Dividend TTM1.74MShs Float65.550Historical High--Div YieldTTM14.34%Amplitude2.100Historical Low2.447Avg Price1Lot Size
Mangoceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 31.85%-1.17M | 11.42%-1.58M | 45.19%-991.13K | -419.66%-7M | -161.37%-1.7M | -184.96%-1.71M | -2,185.38%-1.78M | -9,570.06%-1.81M | -1.35M | -3,607.53%-649.56K |
| Net income from continuing operations | -11.13%-2M | -4.70%-2.39M | 7.55%-2.37M | -361.07%-9.21M | -281.21%-2.57M | -84.50%-1.8M | -593.21%-2.28M | -12,966.41%-2.56M | ---2M | -3,705.75%-673.66K |
| Operating gains losses | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---151.82K | ---- |
| Depreciation and amortization | -95.99%252 | -48.51%3.21K | 2.33%6.22K | 544.29%24.89K | 62.85%6.29K | --6.29K | --6.22K | --6.08K | --3.86K | --3.86K |
| Other non cash items | 300.78%503.21K | 113.43%808.4K | -40.65%416.5K | 178.88%1.52M | 513.31%318.09K | -53.01%125.56K | 67.16%378.77K | 78,838.13%701.76K | --546.54K | 28,554.70%51.87K |
| Change In working capital | 81.83%-19.98K | -634.46%-289.57K | 4,789.18%915.8K | 120.00%41.51K | 108.96%116.84K | -77.25%-109.98K | 116.72%54.18K | ---19.53K | --18.87K | --55.92K |
| -Change in receivables | ---- | ---- | ---- | 131.55%54.98K | ---- | ---- | ---- | ---- | ---174.24K | ---- |
| -Change in inventory | -57.87%806 | 101.84%433 | --4.05K | ---18.5K | --3.08K | --1.91K | ---23.49K | --0 | --0 | --0 |
| -Change in prepaid assets | 142.06%13.3K | 317.60%46.75K | 104.62%902 | -71.53%-49.21K | 159.40%23.43K | 16.16%-31.62K | ---21.49K | ---19.53K | ---28.69K | --9.03K |
| -Change in payables and accrued expense | 192.66%36.21K | -436.02%-335.81K | --911.79K | 204.92%110.97K | 40.26%50.1K | -60.59%-39.07K | 299.75%99.94K | --0 | --36.39K | --35.72K |
| -Change in other current assets | ---- | -45.42%14.78K | --14.47K | ---- | ---- | ---- | --27.08K | --0 | ---- | ---- |
| -Change in other current liabilities | -190.68%-41.04K | 43.57%-15.72K | ---15.41K | -130.60%-56.73K | -107.95%-14.75K | ---14.12K | ---27.86K | --0 | --185.41K | --185.41K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 31.85%-1.17M | 11.42%-1.58M | 45.19%-991.13K | -419.66%-7M | -161.37%-1.7M | -184.96%-1.71M | -2,185.67%-1.78M | -9,564.90%-1.81M | ---1.35M | -3,607.53%-649.56K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 65K | 0 | 91.84%-3.52K | 0 | 0 | 0 | -3.52K | -43.1K | -40.57K |
| Net PPE purchase and sale | ---65K | --65K | --0 | 91.84%-3.52K | --0 | --0 | --0 | ---3.52K | ---43.1K | ---40.57K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --65K | --0 | 91.84%-3.52K | --0 | --0 | --0 | ---3.52K | ---43.1K | ---40.57K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 750K | 131.99%1.99M | -94.65%267.5K | 244.26%7.06M | 140.24%1.2M | 0 | 3,337.79%857.04K | 9,900.00%5M | 2.05M | 1,146.57%499.5K |
| Net issuance payments of debt | --0 | 159.72%100K | --87.5K | -435.39%-167.46K | --0 | --0 | -771.72%-167.46K | --0 | --49.93K | --0 |
| Net common stock issuance | --0 | --388.27K | -96.40%180K | 210.00%6.2M | 140.24%1.2M | --0 | --0 | --5M | --2M | 62,337.50%499.5K |
| Net preferred stock issuance | --750K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --1.02M | --0 | --0 | ---- | ---- | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --750K | 131.99%1.99M | -94.65%267.5K | 244.26%7.06M | 140.24%1.2M | --0 | 3,337.79%857.04K | 9,900.00%5M | --2.05M | 1,146.57%499.5K |
| Net cash flow | ||||||||||
| Beginning cash position | -83.37%490.24K | -99.60%15.31K | 8.22%739.01K | 2,928.20%682.86K | 41.59%1.24M | 339,473.16%2.95M | 7,089.89%3.87M | 2,928.20%682.86K | --22.55K | --873.49K |
| Current changes in cash | 75.69%-415.83K | 151.54%476.03K | -122.70%-723.63K | -91.50%56.15K | -161.10%-497.74K | -296.05%-1.71M | -1,643.46%-923.54K | 10,089.13%3.19M | --660.31K | -945.37%-190.63K |
| Effect of exchange rate changes | ---497 | ---1.1K | ---70 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| End cash Position | -94.02%73.91K | -83.37%490.24K | -99.60%15.31K | 8.22%739.01K | 8.22%739.01K | 41.59%1.24M | 339,473.16%2.95M | 7,089.89%3.87M | --682.86K | 2,928.20%682.86K |
| Free cash flow | 31.85%-1.17M | 11.42%-1.58M | 45.30%-991.13K | -403.80%-7M | -146.00%-1.7M | -183.76%-1.71M | -2,185.67%-1.78M | -9,583.70%-1.81M | ---1.39M | -3,839.10%-690.13K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |